Luis is currently VP of the Delivery Platform at Beam Theraputics. He currently leads a team that is responsible for early research and development non-viral delivery systems to enable base editing. Prior to Beam he was at Moderna Therapeutics for 6 years where he led discovery efforts around novel delivery systems and routes of administration for vaccines and therapeutics. His team was instrumental in selecting, optimizing and characterizing the lead LNP for the Moderna’s COVID vaccine. Before Moderna he was at Novartis Vaccines where he developed delivery systems for RNA vaccines and adjuvants. . He was also involved in leading work on Novartis’s SAM/LNP formulation. Luis recieved his Masters and PhD in Pharmaceutical Sciences from Northeastern University and received his BS in Human Physiology from Boston University.
Luis Brito, PhD
